PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Harrington, Robert A.
TI  - Clinical Effectiveness for Cangrelor in PCI Not Persuasive
DP  - 2009  01
TA  - MD Conference Express
PG  - 12--13
VI  - 9
IP  - 5
4099  - http://mdc.sagepub.com/content/9/5/12.short
4100  - http://mdc.sagepub.com/content/9/5/12.full
AB  - The final results of the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition [CHAMPION] PCI [NCT00305162] and CHAMPION PLATFORM [NCT00385138] trials showed no clinical benefit with cangrelor for the primary composite outcome of death, myocardial infarction, and ischemic-driven revascularization in patients who were undergoing percutaneous coronary intervention.